Novartis India reports net profit at Rs 7.52 crore in Q2
New Delhi: Drug firm Novartis India on Thursday reported a net profit of Rs 7.52 crore for the second quarter ended September 30.
The company had posted a net loss of Rs 5.22 crore for the corresponding period previous fiscal, Novartis India said in a BSE filing.
The total income of the company stood at Rs 101.43 crore for the quarter under consideration.
It was Rs 127.79 crore for the same period last year, it added.
In a separate filing, Novartis India said its board has approved the appointment of Bhavna Gupta as internal auditor of the company.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.